Esperion Therapeutics, Inc. Reports Q2 2025 Financial Results
2025-08-13SEC Filing 10-Q (0001628280-25-040139)
Please check the link below for details.
Tickers mentioned in this filing:ESPR
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1434868/0001628280-25-040139.txt